Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study

Background: Secukinumab has been shown effective for psoriatic arthritis (PsA) and axial spondylarthritis (AxSpA) in randomized trials. The aim of this study was to analyze baseline patient and disease characteristics associated with a better retention rate of secukinumab under real-world conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Dorta, Alicia, León-Suarez, Paola, Peña, Sonia, Hernández-Díaz, Marta, Rodríguez-Lozano, Carlos, González-Dávila, Enrique, Hernández-Hernández, María Vanesa, Díaz-González, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792854/
https://www.ncbi.nlm.nih.gov/pubmed/35096907
http://dx.doi.org/10.3389/fmed.2021.815881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792854/
https://www.ncbi.nlm.nih.gov/pubmed/35096907
http://dx.doi.org/10.3389/fmed.2021.815881

Ejemplares similares